The association of coronary heart disease (CHD) and human immunodeficiency virus (HIV)
infection has been well recognized for many years. The etiology of the increased prevalence …

Dyslipidemias are one of the common metabolic disorders. A link between dermatological
disorders like psoriasis and dyslipidemia has been established in the recent past. Many …

Background & Aims The most prescribed non-nucleoside reverse transcriptase inhibitor,
efavirenz, has been associated with elevated risk of dyslipidemia and hepatic steatosis in …

Objective: To investigate whether there is any association between exposure to atazanavir
(ATV), either when boosted or unboosted by ritonavir, and myocardial infarction (MI) or …

Background and Purpose Many drugs and environmental contaminants induce
hypercholesterolemia and promote the risk of atherosclerotic cardiovascular disease. We …

Background Data on the burden of dyslipidaemia among people with HIV undergoing
antiretroviral therapy (ART) in sub-Saharan Africa are limited and little is known about the …

AIDS is a pandemic disease caused by HIV that affects 37 million people worldwide. Current
antiretroviral therapy slows disease progression but does not eliminate latently infected …

Therefore, aging of the liver in HIV may play a much more pivotal role in the future
considering age-related effects, coinfection with hepatotropic viruses and the toxicity of long …

Background: HIV infection and antiretroviral therapy (ART) have both been linked to
dyslipidemia and increased cardiovascular disease (CVD) risk. Alterations in the …

Globally, the HIV epidemic is evolving. Life expectancy for HIV-infected individuals has been
extended because of more effective and more widely available antiretroviral therapy. As a …